NCT04715607 is a NA clinical trial of Sequence of testing. in SARS-CoV Infection, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT04715607?

NCT04715607 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT04715607?

Interventions in NCT04715607: Sequence of testing..

What condition does NCT04715607 study?

NCT04715607 studies SARS-CoV Infection, Covid19, Coronavirus.

Is NCT04715607 still recruiting?

NCT04715607 is currently completed. Last updated 30 September 2021.

Last reviewed 2021-09-30 · How we verify

NCT04715607

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens

Completed NA Last updated 30 September 2021

What this trial tests

NA trial testing Sequence of testing. in SARS-CoV Infection in 27,947 participants. Completed in 31 May 2021.

Timeline

22 January 2021

Primary endpoint
30 May 2021

31 May 2021

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	27,947
Start date	22 January 2021
Primary completion	30 May 2021
Estimated completion	31 May 2021
Sites	1 location across Denmark

Drugs / interventions tested

Sequence of testing.

Conditions studied

SARS-CoV Infection — all drugs for SARS-CoV Infection →
Covid19 — all drugs for Covid19 →
Coronavirus — all drugs for Coronavirus →

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 16 to 120, any sex, with SARS-CoV Infection or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the SARS-CoV-2 detection rate using either a Saliva, oropharyngeal swabs or nasopharyngeal swab method for specimen collection.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study.
Todsen T, Tolsgaard MG, Benfield T, Folke F, et al · · 2023 · cited 14× · PMID 37208187 · DOI 10.1136/thorax-2022-219599
SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens.
Todsen T, Tolsgaard M, Folke F, Jakobsen KK, et al · · 2021 · cited 10× · PMID 33832565

Verify or expand the search:

Other recruiting trials for SARS-CoV Infection

Currently open trials in the same condition.

NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04715607 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 30 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04715607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing